| Literature DB >> 27513555 |
Judith Becker1, Christoph Wittmann2.
Abstract
For more than fifty years, Escherichia coli has represented a remarkable success story in industrial biotechnology. Traditionally known as a producer of l-amino acids, E. coli has also entered the precious market of high-value molecules and is becoming a flexible, efficient production platform for various therapeutics, pre-biotics, nutraceuticals and pigments. This tremendous progress is enabled by systems metabolic engineering concepts that integrate systems biology and synthetic biology into the design and engineering of powerful E. coli cell factories. Copyright ÂEntities:
Mesh:
Substances:
Year: 2016 PMID: 27513555 DOI: 10.1016/j.copbio.2016.05.004
Source DB: PubMed Journal: Curr Opin Biotechnol ISSN: 0958-1669 Impact factor: 9.740